Search Results - "Veeder, Michael"

Phase III Study of the Eastern Cooperative Oncology Group (ECOG 2597): Induction Chemotherapy Followed by Either Standard Thoracic Radiotherapy or Hyperfractionated Accelerated Radiotherapy for Patients With Unresectable Stage IIIA and B Non–Small-Cell Lung Cancer by BELANI, Chandra P, WEI WANG, JOHNSON, David H, WAGNER, Henry, SCHILLER, Joan, VEEDER, Michael, MEHTA, Minesh

“…To compare once-daily radiation therapy (qdRT) with hyperfractionated accelerated radiation therapy (HART) after two cycles of induction chemotherapy. Eligible…”
Get full text

Long‐term results of the treatment of patients with mantle cell lymphoma with cladribine (2‐CDA) alone (95‐80‐53) or 2‐CDA and rituximab (N0189) in the North Central Cancer Treatment Group by Inwards, David J., Fishkin, Paul A. S., Hillman, David W., Brown, David W., Ansell, Stephen M., Kurtin, Paul J., Fonseca, Rafael, Morton, Roscoe F., Veeder, Michael H., Witzig, Thomas E.

“…BACKGROUND. The objective of this study was to test cladribine (2‐CDA) alone and in combination with rituximab in patients with mantle cell lymphoma (MCL)…”
Get full text

Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma by Moertel, Charles G, Fleming, Thomas R, Macdonald, John S, Haller, Daniel G, Laurie, John A, Goodman, Phyllis J, Ungerleider, James S, Emerson, William A, Tormey, Douglas C, Glick, John H, Veeder, Michael H, Mailliard, James A

“…Twelve hundred ninety-six patients with resected colon cancer that either was locally invasive (Stage B 2 ) or had regional nodal involvement (Stage C) were…”
Get full text

Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma by Krook, James E, Moertel, Charles G, Gunderson, Leonard L, Wieand, Harry S, Collins, Roger T, Beart, Robert W, Kubista, Theodore P, Poon, Michael A, Meyers, William C, Mailliard, James A, Twito, Donald I, Morton, Roscoe F, Veeder, Michael H, Witzig, Thomas E, Cha, Stephen, Vidyarthi, Subhash C

“…CARCINOMA of the rectum is one of the more common malignant diseases in this country, estimated to afflict some 45,500 persons during 1991. 1 It has certainly…”
Get full text

Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial by Burch, Patrick A, Mailliard, James A, Hillman, David W, Perez, Edith A, Krook, James E, Rowland, Kendrith M, Veeder, Michael H, Cannon, Michael W, Ingle, James N

“…This 2-stage, phase II cooperative group trial examined the efficacy and toxicity of 1000 mg/m2 gemcitabine plus 25 mg/m2 cisplatin weekly for 3 weeks and…”
Get full text

A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932 by Perez, Edith A, Suman, Vera J, Fitch, Tom R, Mailliard, James A, Ingle, James N, Cole, John T, Veeder, Michael H, Flynn, Patrick J, Walsh, Daniel J, Addo, Ferdinand K

“…A phase II multi-institutional clinical trial conducted to evaluate the efficacy and tolerability of docetaxel and carboplatin as first-line therapy for women…”
Get more information

A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors by Hong, David, Rasco, Drew, Veeder, Michael, Luke, Jason J, Chandler, Jason, Balmanoukian, Ani, George, Thomas J, Munster, Pamela, Berlin, Jordan D, Gutierrez, Martin, Mita, Alain, Wakelee, Heather, Samakoglu, Selda, Guan, Shanhong, Dimery, Isaiah, Graef, Thorsten, Borazanci, Erkut

“…Ibrutinib, a first-in-class, once-daily inhibitor of Bruton's tyrosine kinase, is approved in the United States for the treatment of various B-cell…”
Get more information

A prospective study of pulmonary function in patients receiving mitomycin by Castro, M, Veeder, M H, Mailliard, J A, Tazelaar, H D, Jett, J R

“…Mitomycin is a chemotherapeutic agent that is used to treat a variety of solid tumors. Pulmonary toxic reactions from this agent can be life threatening. We…”
Get more information

Phase III Clinical Trial of the Combination of Cisplatin, Dacarbazine, and Carmustine With or Without Tamoxifen in Patients With Advanced Malignant Melanoma by CREAGAN, E. T, SUMAN, V. J, DALTON, R. J, PITOT, H. C, LONG, H. J, VEEDER, M. H, VUKOV, A. M, ROWLAND, K. M, KROOK, J. E, MICHALAK, J. C

“…A prospective randomized phase III clinical trial was conducted to assess whether the addition of tamoxifen (TAM) to the three-agent regimen of cisplatin…”
Get full text

A multicenter study of the Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib plus durvalumab in patients with relapsed/refractory (R/R) solid tumors by Hong, David S., Rasco, Drew W., Veeder, Michael H., Luke, Jason J., Chandler, Jason, Balmanoukian, Ani Sarkis, George, Thomas J., Munster, Pamela, Berlin, Jordan, Gutierrez, Martin, Mita, Alain C., Wakelee, Heather A., Samakoglu, Selda, Guan, Shanhong, Dimery, Isaiah W., Borazanci, Erkut

“…Abstract only…”
Get full text

Ibrutinib + durvalumab (MEDI4736) in patients (pts) with relapsed or refractory (R/R) pancreatic adenocarcinoma (PAC): A phase Ib/II multicenter study by Borazanci, Erkut Hasan, Hong, David S., Gutierrez, Martin, Rasco, Drew W., Reid, Tony R., Veeder, Michael H., Tawashi, Ahmed, Lin, Jennifer, Dimery, Isaiah W.

“…Abstract only TPS484 Background: PAC is an aggressive disease characterized by poor prognosis and is inadequately treated with available therapies. Ibrutinib…”
Get full text

The role of radiotherapy in the management of operable locally advanced breast carcinoma by Olson, John E., Neuberg, Donna, Pandya, Kishan J., Richter, Melvyn P., Solin, Lawrence J., Gilchrist, Kennedy W., Tormey, Douglass C., Veeder, Michael, Falkson, Geoffrey

“…BACKGROUND The purpose of this study was to test the role of radiotherapy following total mastectomy, axillary dissection, and adjuvant systemic therapy in the…”
Get full text

Hematologic and cytogenetic spontaneous remission in acute monocytic leukemia (FAB M5b) with trisomy 8 by DACCACHE, Antoine, KIZHAKEKUTTU, Tinoy, SIEBERT, James, VEEDER, Michael

Get full text

Mitoxantrone dose augmentation utilizing filgrastim support in combination with fixed-dose 5-fluorouracil and leucovorin in women with metastatic breast cancer by INGLE, J. N, KARDINAL, C. G, SUMAN, V. J, VEEDER, M. H, SCHAEFER, P. L, KIRSCHLING, R. J, MAILLIARD, J. A

“…Based on reports of substantial antitumor efficacy of the combination of mitoxantrone (DHAD), 5-fluorouracil (FU) and leucovorin (LV), a clinical trial was…”
Get full text

Prospective evaluation of vitamin E for hot flashes in breast cancer survivors by Barton, D L, Loprinzi, C L, Quella, S K, Sloan, J A, Veeder, M H, Egner, J R, Fidler, P, Stella, P J, Swan, D K, Vaught, N L, Novotny, P

“…Hot flashes represent a substantial clinical problem for some breast cancer survivors. Although estrogen or progesterone preparations can alleviate these…”
Get more information

Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma : a final report by MOERTEL, C. G, FLEMING, T. R, VEEDER, M. H, MAILLIARD, J. A, MACDONALD, J. S, HALLER, D. G, LAURIE, J. A, TANGEN, C. M, UNGERLEIDER, J. S, EMERSON, W. A, TORMEY, D. C, GLICK, J. H

Get full text

Transdermal clonidine for ameliorating tamoxifen-induced hot flashes by Goldberg, R M, Loprinzi, C L, O'Fallon, J R, Veeder, M H, Miser, A W, Mailliard, J A, Michalak, J C, Dose, A M, Rowland, Jr, K M, Burnham, N L

“…To determine the efficacy of transdermal clonidine for alleviating tamoxifen-induced hot flashes in women with a history of breast cancer. A randomized,…”
Get more information

O-125 ECOG 2597: Phase III study of induction chemotherapy followed by standard thoracic radiotherapy (STD TRT) vs hyperfractionated accelerated radiotherapy (HART) for patients with unresectable stage III A & B non-small cell lung cancer by Belani, Chandra Prakash, Wang, Wei, Johnson, David H., Wagner, Henry, Schiller, Joan, Veeder, Michael, Mehta, Minesh

Get full text

A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma by Ingle, James N., Suman, Vera J., Kardinal, Carl G., Krook, James E., Mailliard, James A., Veeder, Michael H., Loprinzi, Charles L., Dalton, Robert J., Hartmann, Lynn C., Conover, Cheryl A., Pollak, Michael N.

“…BACKGROUND Tamoxifen (TAM) is generally considered the hormonal agent of choice for postmenopausal women with hormone receptor positive breast carcinoma. The…”
Get full text

The role of radiotherapy in the management of operable locally advanced breast carcinoma: Results of a randomized trial by the Eastern Cooperative Oncology Group by OLSON, J. E, NEUBERG, D, PANDYA, K. J, RICHTER, M. P, SOLIN, L. J, GILCHRIST, K. W, TORMEY, D. C, VEEDER, M, FALKSON, G

“…The purpose of this study was to test the role of radiotherapy following total mastectomy, axillary dissection, and adjuvant systemic therapy in the management…”
Get full text